Relaro Medical Trials, LLC

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Autism2 trials
• Depression2 trials
• Schizophrenia1 trial

Phase

• Phase 24 trials
• Phase 2/32 trials
• Phase 31 trial

Status

• Completed6 trials
• Terminated1 trial

Lead sponsor

• ACADIA Pharmaceuticals Inc.2 trials
• Biohaven Therapeutics Ltd.2 trials
• Boehringer Ingelheim2 trials
• Jazz Pharmaceuticals1 trial

Closed trials

• Completed

  Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)

  NCT06423781· Phase 2· Biohaven Therapeutics Ltd.· Source

• Completed

  Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

  NCT06419608· Phase 2· Biohaven Therapeutics Ltd.· Source

• Terminated

  Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

  NCT05555615· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

• Completed

  Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

  NCT05523895· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

• Completed

  A Study of JZP150 in Adults With Posttraumatic Stress Disorder

  NCT05178316· Phase 2· Jazz Pharmaceuticals· Source

• Completed

  A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

  NCT05103657· Phase 2· Boehringer Ingelheim· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· Phase 3· Boehringer Ingelheim· Source